With the exception of the tumors associated with familial syndromes, studies on genetic alterations [15]–[19] and biomarkers such as epidermal growth factor receptor (EGFR) and HER2 status [7], [17], [20] of apocrine-eccrine carcinomas are few in number. This evidence concerns the gene ERBB2 and eccrine carcinoma.